Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-02-01

FDA Approved: LEVETIRACETAM — Supplemental Application (Prasco Laboratories)

View source ↗

Summary

FDA approved a supplemental application for Levetiracetam submitted by Prasco Laboratories. The update concerns changes to the product labeling under the supple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LEVETIRACETAM (levetiracetam)

Snippet

SUPPL AP for LEVETIRACETAM (LEVETIRACETAM)